Cancer

CUNY SPH receives $5.2 million NIH grant renewal for cancer genomics research

NEW YORK, June 25, 2024 /PRNewswire/ -- The Informatics Technology for Cancer Research (ITCR) program of the NIH National Cancer…

2 years ago

Lilly collaborates with OpenAI to discover novel medicines to treat drug-resistant bacteria

INDIANAPOLIS, June 25, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced a collaboration with OpenAI that will allow…

2 years ago

Function Emerges as the Fastest-Growing Health Platform in the US with Unique Approach that Starts with 100+ Lab Tests

The company's latest $53M raise will help further its mission of empowering everyone to live 100 healthy years AUSTIN, Texas,…

2 years ago

Erie County Medical Center Leverages Brook Health’s AI and Remote Care Platform to Transform Hypertension Management

Collaboration Doubles Blood Pressure Control for High-Risk Patients in 12 Weeks BUFFALO, N.Y., June 25, 2024 /PRNewswire/ -- Brook Health,…

2 years ago

Carrum Health Expands Cancer Care Solution to Over 400 Facilities Nationwide, Extending Value-Based Treatment for Nearly All Cancer Types

Carrum now has the largest Centers of Excellence network for cancer care in the country offering high quality local access…

2 years ago

Alpha Tau Announces Publication in Cancers Journal of Long-Term Safety and Efficacy Data in Multiple Hard-to-Treat Superficial Cancers

The pooled analysis included data from 4 international clinical trials spanning an array of hard-to-treat indications including skin, head &…

2 years ago

Industry Leader John Maraganore, Ph.D., Joins Cybrexa Therapeutics as Strategic Advisor

NEW HAVEN, Conn., June 25, 2024 (GLOBE NEWSWIRE) -- Cybrexa Therapeutics, a clinical-stage oncology biotechnology company developing a novel class…

2 years ago

Tevogen Bio Announces Publication of Positive Phase I Clinical Trial Results for TVGN 489 in Blood Advances

WARREN, N.J., June 25, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. (“Tevogen” or “Tevogen Bio”) (Nasdaq: TVGN), a clinical-stage…

2 years ago

Monopar Announces MNPR-101-RIT Abstract Accepted as a Top-Rated Oral Presentation at EANM’24

WILMETTE, Ill., June 25, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage radiopharma company focused on developing…

2 years ago

Tonix Pharmaceuticals Presents Vaccine Platform Data in Keynote Talk at the Vaccine Congress 2024

Tonix’s live virus vaccine TNX-801 is designed to provide long-term protection from mpox and smallpox with one dose TNX-801 vaccination…

2 years ago